414 related articles for article (PubMed ID: 26424649)
21. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
Kasahara Y; Yachie A
Crit Rev Oncol Hematol; 2002 Dec; 44(3):283-94. PubMed ID: 12467968
[TBL] [Abstract][Full Text] [Related]
22. [Anything that can go wrong: cytotoxic cells and their control of Epstein-Barr virus].
Gutiérrez-Guerrero A; Espinosa-Padilla SE; Lugo-Reyes SO
Rev Alerg Mex; 2024 Feb; 71(1):29-39. PubMed ID: 38683066
[TBL] [Abstract][Full Text] [Related]
23. Natural Killer cell transcriptome during primary EBV infection and EBV associated Hodgkin Lymphoma in children-A preliminary observation.
M A; Chatterjee S; A P; S M; Davuluri S; Ar AK; T A; M P; Cs P; Sinha M; Chugani A; R VP; Kk A; R S J
Immunobiology; 2020 May; 225(3):151907. PubMed ID: 32044149
[TBL] [Abstract][Full Text] [Related]
24. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
[TBL] [Abstract][Full Text] [Related]
25. The Role of NK Cells in EBV Infection and EBV-Associated NPC.
Png YT; Yang AZY; Lee MY; Chua MJM; Lim CM
Viruses; 2021 Feb; 13(2):. PubMed ID: 33671917
[TBL] [Abstract][Full Text] [Related]
26. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.
Tsuge I; Morishima T; Kimura H; Kuzushima K; Matsuoka H
J Med Virol; 2001 Jun; 64(2):141-8. PubMed ID: 11360246
[TBL] [Abstract][Full Text] [Related]
27. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
Tatfi M; Hermine O; Suarez F
Front Immunol; 2018; 9():3060. PubMed ID: 30662441
[TBL] [Abstract][Full Text] [Related]
29. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis.
Asada H; Miyagawa S; Sumikawa Y; Yamaguchi Y; Itami S; Suguri S; Harada M; Tokura Y; Ishihara S; Ohshima S; Yoshikawa K
Arch Dermatol; 2003 Dec; 139(12):1601-7. PubMed ID: 14676078
[TBL] [Abstract][Full Text] [Related]
30. Genetic susceptibility to EBV infection: insights from inborn errors of immunity.
Tangye SG
Hum Genet; 2020 Jun; 139(6-7):885-901. PubMed ID: 32152698
[TBL] [Abstract][Full Text] [Related]
31. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
32. Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8
Cannons JL; Preite S; Kapnick SM; Uzel G; Schwartzberg PL
Front Immunol; 2018; 9():1758. PubMed ID: 30116245
[TBL] [Abstract][Full Text] [Related]
33. Primary immunodeficiencies and the control of Epstein-Barr virus infection.
Palendira U; Rickinson AB
Ann N Y Acad Sci; 2015 Nov; 1356():22-44. PubMed ID: 26415106
[TBL] [Abstract][Full Text] [Related]
34. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Zhizhuo H; Junmei X; Yuelin S; Qiang Q; Chunyan L; Zhengde X; Kunling S
Pediatr Blood Cancer; 2012 Mar; 58(3):410-4. PubMed ID: 21674762
[TBL] [Abstract][Full Text] [Related]
35. Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency Disorders.
McLaughlin LP; Bollard CM; Keller MD
Front Immunol; 2018; 9():556. PubMed ID: 29616044
[TBL] [Abstract][Full Text] [Related]
36. [Chronic active Epstein-Barr virus infection].
Kimura H
Uirusu; 2011 Dec; 61(2):163-73. PubMed ID: 22916563
[TBL] [Abstract][Full Text] [Related]
37. Genetics of Epstein-Barr virus infection.
Hiraki A; Fujii N; Masuda K; Ikeda K; Tanimoto M
Biomed Pharmacother; 2001 Sep; 55(7):369-72. PubMed ID: 11669499
[TBL] [Abstract][Full Text] [Related]
38. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
39. Virological aspects of Epstein-Barr virus infections.
Yamashita N; Kimura H; Morishima T
Acta Med Okayama; 2005 Dec; 59(6):239-46. PubMed ID: 16418766
[TBL] [Abstract][Full Text] [Related]
40. Role of human natural killer cells during Epstein-Barr virus infection.
Münz C
Crit Rev Immunol; 2014; 34(6):501-7. PubMed ID: 25597312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
